Kirk Allen Coleman
Net Worth

Last updated:

What is Kirk Allen Coleman net worth?

The estimated net worth of Mr. Kirk Allen Coleman is at least $2,274,836 as of 15 Aug 2023. He owns shares worth $4,816 as insider, has earned $100,000 from insider trading and has received compensation worth at least $2,170,020 in TFF Pharmaceuticals, Inc..

What is the salary of Kirk Allen Coleman?

Mr. Kirk Allen Coleman salary is $361,670 per year as Chief Financial Officer, Treasurer & Sec. in TFF Pharmaceuticals, Inc..

How old is Kirk Allen Coleman?

Mr. Kirk Allen Coleman is 52 years old, born in 1973.

What stocks does Kirk Allen Coleman currently own?

As insider, Mr. Kirk Allen Coleman owns shares in one company:

Company Title Shares Price per share Total value
TFF Pharmaceuticals, Inc. (TFFP) Chief Financial Officer, Treasurer & Sec. 35,675 $0.14 $4,816

What does TFF Pharmaceuticals, Inc. do?

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's lead drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products, such as cannabidiol substance for the treatment of various epilepsy syndromes, as well as anxiety, insomnia, and various pain; Inhaled SARS-CoV2 Monoclonal Antibody for the treatment of patients with COVID-19 infections; Niclosamide Inhalation Powder to treat tapeworm infections in humans, as well as COVID-19 disease; and other vaccines. The company has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop inhaled SARS-CoV2 monoclonal antibody; and a licensing and collaboration agreement with UNION therapeutics A/S. The company was incorporated in 2018 and is based in Austin, Texas.

TFFP logo
TFFP
TFF Pharmaceuticals, Inc.
$0.14

Kirk Allen Coleman insider trading

TFF Pharmaceuticals, Inc.

Mr. Kirk Allen Coleman has made 5 insider trades between 2019-2023, according to the Form 4 filled with the SEC. Most recently he purchased 20,000 units of TFFP stock worth $5,000 on 15 Aug 2023.

The largest trade he's ever made was exercising 20,000 units of TFFP stock on 15 Aug 2023. As of 15 Aug 2023 he still owns at least 35,675 units of TFFP stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 20,000 $0.25 $5,000
Purchase
Common Stock 12,000 $0.79 $9,456
Purchase
Common Stock 425 $4.83 $2,053
Purchase
Common Stock 1,250 $4.4 $5,500
Purchase
Common Stock 1,000 $7.3 $7,300
Option
Stock Options (Right to Buy) 5,000 $2.5 $12,500
Sale
Common Stock 5,000 $2.5 $12,500
Option
Common Stock 5,000 $2.5 $12,500
Option
Stock Options (Right to Buy) 5,000 $2.5 $12,500
Option
Common Stock 5,000 $2.5 $12,500
Sale
Common Stock 5,000 $2.5 $12,500
Option
Common Stock 5,000 $2.5 $12,500
Option
Stock Options (Right to Buy) 5,000 $2.5 $12,500
Sale
Common Stock 5,000 $2.5 $12,500
Sale
Common Stock 10,000 $2.5 $25,000
Option
Stock Options (Right to Buy) 10,000 $2.5 $25,000
Option
Common Stock 10,000 $2.5 $25,000
Option
Stock Options (Right to Buy) 15,000 $2.5 $37,500
Option
Common Stock 15,000 $2.5 $37,500
Sale
Common Stock 15,000 $2.5 $37,500
Purchase
Common Stock 1,000 N/A N/A

TFF Pharmaceuticals key executives

TFF Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: